| For: | Apostolov R, Gianatti E, Wong D, Kutaiba N, Gow P, Grossmann M, Sinclair M. Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations. World J Hepatol 2022; 14(4): 754-765 [PMID: 35646271 DOI: 10.4254/wjh.v14.i4.754] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v14/i4/754.htm |
| Number | Citing Articles |
| 1 |
Nabil Eid, Payal Bhatnagar, Li-Li Chan, Marina Garcia-Macia. Suppression of hepatic steatosis in non-alcoholic steatohepatitis model by modified Xiaoyao San formula: Evidence, mechanisms and perspective. World Journal of Hepatology 2024; 16(10) doi: 10.4254/wjh.v16.i10.1388
|
| 2 |
Nora Cazzagon, Martina Gambato, Maurizia Rossana Brunetto, Erica Villa, Patrizia Burra, Annarosa Floreani. Sex Hormones and the Liver: Implications for Disease Progression and Hormonal Therapy. Liver International 2026; 46(2) doi: 10.1111/liv.70509
|
| 3 |
Kasiani Papadimitriou, Athanasios C. Mousiolis, Gesthimani Mintziori, Christina Tarenidou, Stergios A. Polyzos, Dimitrios G. Goulis. Hypogonadism and nonalcoholic fatty liver disease. Endocrine 2024; 86(1) doi: 10.1007/s12020-024-03878-1
|
| 4 |
Alvile Kasarinaite, Matthew Sinton, Philippa T. K. Saunders, David C. Hay. The Influence of Sex Hormones in Liver Function and Disease. Cells 2023; 12(12) doi: 10.3390/cells12121604
|
| 5 |
Nicola Caretta, Raffaele Scafa, Andrea Graziani, Maria Cristina Crepaldi, Monica Vedovato, Angelo Avogaro, Alberto Ferlin. Noninvasive Indices of MASLD Are Associated With Hypogonadism in Male Patients With Type 2 Diabetes Mellitus. The Journal of Clinical Endocrinology & Metabolism 2024; 109(2) doi: 10.1210/clinem/dgad586
|
| 6 |
Alessandro Cherubini, Sara Della Torre, Serena Pelusi, Luca Valenti. Sexual dimorphism of metabolic dysfunction-associated steatotic liver disease. Trends in Molecular Medicine 2024; 30(12) doi: 10.1016/j.molmed.2024.05.013
|
| 7 |
Chia-Chu Liu, Shu-Pin Huang, Yung-Chin Lee, Cheng-Hsueh Lee, Tsung-Yi Huang, Jiun-Hung Geng, Che-Wei Chang, Chung-Yu Lin, Yung-Shun Juan, Wen-Jeng Wu, Tusty-Jiuan Hsieh. Metabolic dysfunction-associated fatty liver disease is an early predictor for testosterone deficiency in aging men without metabolic syndrome. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1252774
|
| 8 |
Yuchang Li, Vassilios Papadopoulos. Testosterone replacement therapy in metabolic dysfunction-associated steatotic liver disease: a bench-to-bedside narrative review. Exploration of Digestive Diseases 2026; 5 doi: 10.37349/edd.2026.1005135
|
| 9 |
Ziteng Zhang, Chi Chen, Yuying Wang, Ningjian Wang, Yi Chen, Yingli Lu, Fangzhen Xia. The associations of total testosterone with probable nonalcoholic steatohepatitis and nonalcoholic fatty liver disease fibrotic progression in men with type 2 diabetes: a cross-sectional study. European Journal of Medical Research 2022; 27(1) doi: 10.1186/s40001-022-00958-8
|
| 10 |
José Leandro S. Souza, Gabriel S. Rocha, José M. M. Bispo, Ana C. A. Luz, Regina H. Silva, Alessandra M. Ribeiro, Katty A. A. L. Medeiros, Auderlan M. Gois, Marco A. M. Freire, Jose R. Santos. Testosterone replacement therapy in Parkinson’s disease a narrative review of current evidence. Discover Neuroscience 2026; 21(1) doi: 10.1186/s13064-026-00335-9
|
| 11 |
Elena Gangitano, Francesca Scannapieco, Carla Lubrano, Lucio Gnessi. Metabolic Syndrome, Hepatic Steatosis and Testosterone: A Matter of Sex. Livers 2024; 4(4) doi: 10.3390/livers4040038
|
| 12 |
Hae Seung Lee, Sang Hun Han, Ronald Swerdloff, Youngju Pak, Matthew Budoff, Christina Wang. The Effect of Testosterone Replacement Therapy on Nonalcoholic Fatty Liver Disease in Older Hypogonadal Men. The Journal of Clinical Endocrinology & Metabolism 2024; 109(2) doi: 10.1210/clinem/dgad511
|
| 13 |
Guixin Li, Weiwei Liu, Ruihua Chen, Jinghui Guo, Long Wang. Sex Hormone‐Based Models Outperform Conventional Scores for Metabolic Dysfunction‐Associated Steatotic Liver Disease Screening: A Sex‐Specific Analysis in Type 2 Diabetes. Journal of Diabetes Research 2026; 2026(1) doi: 10.1155/jdr/2030936
|
| 14 |
Yapeng Zhang, Haoran Xu, Hede Zou, Wei Lin, Wenkang Chen, Jiayou Zhao. The Liver–Testis Axis: Molecular Mechanisms and Clinical Implications. International Journal of Molecular Sciences 2026; 27(13) doi: 10.3390/ijms27135873
|
| 15 |
Nabil Eid, Payal Bhatnagar, Li-Li Chan, Marina Garcia-Macia. Suppression of hepatic steatosis in non-alcoholic steatohepatitis model by modified Xiaoyao San formula: Evidence, mechanisms and perspective. World Journal of Hepatology 2024; 16(10): 1208-1212 doi: 10.4254/wjh.v16.i10.1208
|
| 16 |
L. J. Yang, J. Z. Zhou, Y. F. Zheng, X. Hu, Z. Y. He, L. J. Du, X. Gu, X. Y. Huang, J. Li, Y. Q. Li, L. Y. Pan, X. X. Zhang, X. J. Gu. Association of non-alcoholic fatty liver disease with total testosterone in non-overweight/obese men with type 2 diabetes mellitus. Journal of Endocrinological Investigation 2023; 46(8) doi: 10.1007/s40618-023-02006-6
|
| 17 |
Eleni Myrto Trifylli, Christiana Charalambous, Nikolaos Spiliotopoulos, Nikolaos Papadopoulos, Anastasia Oikonomou, Spilios Manolakopoulos, Melanie Deutsch. Implication of the Androgen Receptor in Muscle–Liver Crosstalk: An Overlooked Mechanistic Link in Lean-MASLD. Livers 2025; 5(4) doi: 10.3390/livers5040065
|
| 18 |
Adrian M Gonzalez-Gil, Yoann Barnouin, Alessandra Celli, Viola Viola, Marcos D Villarreal, Maria Liza Duremdes Nava, Adam Sciuk, Clifford Qualls, Reina Armamento-Villareal, Dennis T Villareal. Metabolic Effects of Testosterone Added to Intensive Lifestyle Intervention in Older Men With Obesity and Hypogonadism. The Journal of Clinical Endocrinology & Metabolism 2025; 110(3) doi: 10.1210/clinem/dgae249
|
| 19 |
Alvile Kasarinaite, Maria Jimenez Ramos, Mariana Beltran-Sierra, Elena F. Sutherland, Pedro Arede Rei, Make Zhao, Ying Chi, Meryam Beniazza, Andrea Corsinotti, Timothy J. Kendall, Neil C. Henderson, Jonathan A. Fallowfield, Philippa T. K. Saunders, David C. Hay. Hormone correction of dysfunctional metabolic gene expression in stem cell-derived liver tissue. Stem Cell Research & Therapy 2025; 16(1) doi: 10.1186/s13287-025-04238-0
|
| 20 |
Ashley S. Meakin, Peter W. Nathanielsz, Cun Li, Vicki L. Clifton, Michael D. Wiese, Janna L. Morrison. Maternal obesity impacts fetal liver androgen signalling in a sex-specific manner. Life Sciences 2024; 337 doi: 10.1016/j.lfs.2023.122344
|
| 21 |
Yingying Fan, Yujie Ren, Liqun Deng, Dongying Lv, Jiayan Chen, Yun Ling, Jue Tu, Xiaoping Xu, Dejun Wang, Zhaowei Cai. Testosterone deficiency aggravates diet-induced non-alcoholic fatty liver disease by inducing hepatocyte ferroptosis via targeting BMAL1 in mice. International Immunopharmacology 2025; 144 doi: 10.1016/j.intimp.2024.113641
|
| 22 |
Ross Apostolov, Darren Wong, Elizabeth Low, Karl Vaz, Jessica Spurio, Thomas Worland, Dorothy Liu, Roseanne Kimberley Chan, Paul Gow, Mathis Grossmann, Marie Sinclair. Testosterone is lower in men with non-alcoholic fatty liver disease and alcohol-related cirrhosis and is associated with adverse clinical outcomes. Scandinavian Journal of Gastroenterology 2023; 58(11) doi: 10.1080/00365521.2023.2220857
|
| 23 |
Tomomi Taguchi, Shiori Ito, Rei Fujishima, Naoya Shimizu, Wataru Hagiwara, Kenta Matoba, Masatoshi Hirose, Akinori Hayashi, Koji Takano, Takeshi Miyatsuka. Hypertriglyceridemia and younger age are associated with effectiveness of growth hormone therapy on hepatic steatosis. Endocrine Journal 2025; 72(4) doi: 10.1507/endocrj.EJ24-0481
|
| 24 |
Maya Mahmoud, Hassan Kawtharany, Mohamed Awali, Nadine Mahmoud, Islam Mohamed, Wing-Kin Syn. The Effects of Testosterone Replacement Therapy in Adult Men With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Meta-analysis. Clinical and Translational Gastroenterology 2025; 16(1) doi: 10.14309/ctg.0000000000000787
|
| 25 |
Ralf Weiskirchen, Amedeo Lonardo. Sex Hormones and Metabolic Dysfunction-Associated Steatotic Liver Disease. International Journal of Molecular Sciences 2025; 26(19) doi: 10.3390/ijms26199594
|